Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Emerg Drugs. 2011 Sep;16(3):587-96. doi: 10.1517/14728214.2011.609168. Epub 2011 Aug 12.

Emerging pharmacotherapy for obesity.

Author information

1
Comprehensive Weight Control Program, Weill-Cornell Medical College, NY 10065, USA. ljaronne@mail.med.cornell.edu

Abstract

INTRODUCTION:

Obesity is a rapidly increasing global health problem. The rates of obesity have tripled over the past three decades and are predicted to rise even further. The need for safe and effective therapies is great and has gone unmet.

AREAS COVERED:

This review will summarize the emerging pharmacological treatments for obesity. The research discussed includes Phase III and early-phase clinical trials as well as recently published data regarding emerging treatment therapies.

EXPERT OPINION:

The new generation of anti-obesity drugs offers hope in the management of obesity, but no single agent is likely to be a panacea. Treatment of obesity will likely use multiple medications to achieve the desired result. Additionally, in light of the challenges faced by drug companies in order to gain FDA approval for an obesity therapy, the future approach may be to seek approval for obesity-related co-morbidities. This approach would enhance the ability of physicians to practice 'weight-centric' disease management.

PMID:
21834735
DOI:
10.1517/14728214.2011.609168
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center